Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Hematol Oncol
; 41(3): 590-593, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-36416678
Full text:
1
Database:
MEDLINE
Main subject:
Multiple Myeloma
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Year:
2023
Type:
Article